Chapters

Transcript

Video

What are the current price differences between the originator product such as brand/originator versions for infliximab versus the biosimilar? Does it vary from country to country?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Jonathan Kay, MD

Jonathan Kay, MD

Director of Clinical Research
Rheumatology Division
Professor of Medicine
University of Massachusetts Medical School
Worcester, MA